News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,305 Results
Type
Article (50023)
Company Profile (309)
Press Release (674973)
Section
Business (212054)
Career Advice (2929)
Deals (36494)
Drug Delivery (108)
Drug Development (83801)
Employer Resources (179)
FDA (16627)
Job Trends (15614)
News (359135)
Policy (34602)
Tag
Academia (2807)
Alliances (51173)
Alzheimer's disease (1306)
Approvals (16551)
Artificial intelligence (154)
Bankruptcy (361)
Best Places to Work (12029)
Biotechnology (216)
Breast cancer (189)
Cancer (1364)
Cardiovascular disease (115)
Career advice (2467)
Cell therapy (287)
Clinical research (66645)
Collaboration (460)
Compensation (253)
COVID-19 (2715)
C-suite (110)
Data (1381)
Diabetes (169)
Diagnostics (6404)
Drug pricing (98)
Earnings (88193)
Employer resources (157)
Events (115473)
Executive appointments (372)
FDA (17266)
Funding (418)
Gene therapy (214)
GLP-1 (649)
Government (4691)
Healthcare (19732)
Infectious disease (2807)
Inflammatory bowel disease (115)
Interviews (522)
IPO (16763)
Job creations (3992)
Job search strategy (2059)
Layoffs (456)
Legal (8503)
Lung cancer (194)
Manufacturing (207)
Medical device (13710)
Medtech (13715)
Mergers & acquisitions (19858)
Metabolic disorders (462)
Neuroscience (1638)
NextGen Class of 2024 (6999)
Non-profit (4822)
Northern California (1662)
Obesity (264)
Opinion (234)
Patents (118)
People (58172)
Phase I (20679)
Phase II (29280)
Phase III (21945)
Pipeline (512)
Postmarket research (2751)
Preclinical (8946)
Radiopharmaceuticals (242)
Rare diseases (274)
Real estate (6262)
Regulatory (22859)
Research institute (2503)
Resumes & cover letters (483)
Southern California (1445)
Startups (3762)
United States (15100)
Vaccines (620)
Weight loss (196)
Date
Last 7 days (693)
Last 30 days (2413)
Last 365 days (36218)
2024 (35397)
2023 (41190)
2022 (52491)
2021 (57213)
2020 (55913)
2019 (48889)
2018 (37104)
2017 (33941)
2016 (33802)
2015 (39671)
2014 (33358)
2013 (28530)
2012 (30756)
2011 (31348)
2010 (29373)
Location
Africa (880)
Arizona (209)
Asia (40330)
Australia (6715)
California (3752)
Canada (1420)
China (300)
Colorado (171)
Connecticut (179)
Europe (88381)
Florida (521)
Georgia (132)
Illinois (390)
Indiana (226)
Maryland (634)
Massachusetts (2952)
Michigan (170)
Minnesota (289)
New Jersey (1083)
New York (1058)
North Carolina (797)
Northern California (1662)
Ohio (146)
Pennsylvania (908)
South America (1287)
Southern California (1445)
Texas (538)
Utah (108)
Washington State (395)
725,305 Results for "one lambda inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biofrontera Inc. to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
December 3, 2024
·
4 min read
Sebia Receives U.S. FDA Clearance for the FLC Kappa & Lambda Assays
Sebia, a global specialty diagnostic company providing innovative solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the FLC Kappa & Lambda assays.
February 29, 2024
·
2 min read
Press Releases
Increasing Possibility of Success by Expanded Antibody Repertoires with Lambda Light Chain - Immunocan Launches New Mouse Strain of Fully Human Antibody Platform: ImmuMab® HKL Mouse
July 18, 2024
·
4 min read
Press Releases
Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC
December 4, 2024
·
1 min read
Drug Development
Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis Delta
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for rare metabolic diseases, today announced its decision to discontinue the Phase 3 LIMT-2 study of peginterferon lambda in patients with chronic hepatitis delta (CHD).
September 12, 2023
·
4 min read
Genetown
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14th Annual East Coast IDEAS Conference at the Jay Conference Center – Bryant Park in New York City on June 12, 2024.
June 6, 2024
·
1 min read
Biotech Bay
PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows
PhenomeX Inc., a functional cell biology company, is pleased to announce that GSK will present data on the SpotLight™ Human Lambda reagent for the Beacon® platform at the 16th annual Conference on Protein Expression in Animal Cells, which is being held in Sitges, Spain from September 24-28, 2023.
September 21, 2023
·
3 min read
Inc. Magazine Names Xenco Medical one of the Best Companies to Work for in America
Inc. Magazine has named trailblazing life sciences company Xenco Medical one of the best companies to work for in America.
June 18, 2024
·
2 min read
Pharm Country
One-on-One, Surgeon-to-Surgeon Bunionplasty® Procedure Training Program Sets New Industry Standard for Minimally Invasive Bunion Surgery Adoption
Voom™ Medical Devices, Inc. (“Voom”), a revolutionary medical device company transforming the landscape of minimally invasive bunion surgery (MIBS) education, is thrilled to announce the official launch of its new one-on-one surgeon training program for the Bunionplasty® 360 Bunion Repair™ procedure.
March 27, 2024
·
2 min read
BioMidwest
Bio-Techne Announces Launch of Kappa and Lambda RNAscope ISH Probes as Analyte Specific Reagents (ASRs) for the Detection of Immunoglobulin Kappa and Lambda Light Chains mRNA
Bio-Techne announced the launch of two new RNAscope™ in situ Hybridization Probes Kappa and Lambda as analyte specific reagents for the detection of immunoglobulin kappa and lambda light chains mRNA in B-cells.
May 10, 2023
·
2 min read
1 of 72,531
Next
